跳至主要内容
临床试验/NCT04098172
NCT04098172已完成不适用

A Prospective, Multicenter Study to Evaluate the Performance and Safety of CometTM Pressure Guidewire in the Measurement of FFR in Chinese Patients

Boston Scientific Corporation2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2019年9月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
2
主要终点
Fractional Flow Reserve (FFR)

研究概览

简要总结

A prospective, open-label, multi-center study designed to validate the agreement of CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements

详细描述

The COMET China study is a prospective, open-label, multi-center study designed to validate the agreement of CometTM Pressure Guidewire and Pressure Wire Certus® in FFR measurements. Patient with stable angina or any form of non-ST elevation acute coronary syndrome, who are scheduled for diagnostic angiography and pressure wire assessment, and signed the informed consent, will be screened for enrollment in this study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient must be at least 18 years old and less than or equal to 75 years of age
  • Patient or his/her legally-authorized representative agrees to sign the EC-approved ICF prior to the procedure
  • Patient with stable angina or any form of non-ST elevation acute coronary syndrome and is clinically indicated of intra-coronary diagnostic angiography and FFR assessment
  • Angiographic Inclusion Criteria:
  • Moderate stenosis (30% to 70% diameter stenosis by visual estimation) is detected at diagnostic angiography

排除标准

  • Patients unable to provide informed consent
  • Patients in pregnant state
  • Known renal insufficiency or failure (serum creatinine level of > 2.5 mg/dL, or on dialysis)
  • Allergy to the contrast
  • Significant arrhythmia, such as II degree or above of atrioventricular block, Sick sinus syndrome, ventricular tachycardia
  • Spastic bronchial asthma
  • ST elevation coronary syndrome
  • Hemodynamic instability
  • Contraindication to nitroglycerin or ATP
  • Current participation in another investigational drug or device clinical study that may affect the FFR measurements
  • Angiographic Exclusion Criteria:
  • CTO lesion Severe vessel tortuosity at the stenotic segments Culprit vessel of non-ST-segment elevation acute myocardial infarction

结局指标

主要结局

Fractional Flow Reserve (FFR)

时间窗: during procedure, 1 hour

All eligible subjects will receive FFR measurements simultaneously by both CometTM Pressure Guidewire and Pressure wires Certus®. Fractional flow reserve (FFR) measurement involves determining the ratio between the maximum achievable blood flow in a diseased coronary artery and the theoretical maximum flow in a normal coronary artery. An FFR of 1.0 is widely accepted as normal. An FFR lower than 0.75-0.80 is generally considered to be associated with myocardial ischemia (MI). Agreement between the method of measurement will be confirmed if both conditions are met: The mean paired difference is within +/- 0.005

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Evaluate the Performance and Safety of Comet... | 临床试验